Identification of three exercise-induced mortality risk factors in patients with COPD

COPD: Journal of Chronic Obstructive Pulmonary Disease

Volumn 11, Issue 6, 2014, Pages 615-626

  Yoshimura, Kenji ^a   Maekura, Ryoji ^a   Hiraga, Toru ^a   Miki, Keisuke ^a   Kitada, Seigo ^a   Miki, Mari ^a   Tateishi, Yoshitaka ^a   Mori, Masahide ^a  

^a TONEYAMA NATIONAL HOSPITAL   (Japan)

Author keywords

Exercise capacity; Exercise induced hypoxemia; Progressive respiratory acidosis; Survival rate; Sympathetic overactivity

Indexed keywords

NORADRENALIN;

AGED; ARTERIAL OXYGEN TENSION; ARTERIAL PH; ARTICLE; CAUSE OF DEATH; CHRONIC OBSTRUCTIVE LUNG DISEASE; COHORT ANALYSIS; DISEASE ASSOCIATION; EXERCISE TEST; FEMALE; FOLLOW UP; HUMAN; HYPOXEMIA; MAJOR CLINICAL STUDY; MALE; NORADRENALIN BLOOD LEVEL; OBSERVATIONAL STUDY; OXYGEN CONSUMPTION; OXYGEN TENSION; PATHOPHYSIOLOGY; PROGNOSIS; PROSPECTIVE STUDY; RESPIRATORY ACIDOSIS; RESPIRATORY FAILURE; RISK FACTOR; SPIROMETRY; SURVIVAL; SYMPATHETIC FUNCTION; ACIDOSIS, RESPIRATORY; ADRENERGIC SYSTEM; ANOXIA; BLOOD; EXERCISE; EXERCISE TOLERANCE; KAPLAN MEIER METHOD; MIDDLE AGED; MORTALITY; PH; PHYSIOLOGY; PRESSURE; SEVERITY OF ILLNESS INDEX; SURVIVAL RATE;

ACIDOSIS, RESPIRATORY; AGED; ANOXIA; EXERCISE; EXERCISE TEST; EXERCISE TOLERANCE; FEMALE; HUMANS; HYDROGEN-ION CONCENTRATION; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; NOREPINEPHRINE; OXYGEN CONSUMPTION; PARTIAL PRESSURE; PROSPECTIVE STUDIES; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RISK FACTORS; SEVERITY OF ILLNESS INDEX; SURVIVAL RATE; SYMPATHETIC NERVOUS SYSTEM;

EID: 84910636734     PISSN: 15412555     EISSN: 15412563     Source Type: Journal    
DOI: 10.3109/15412555.2014.898038     Document Type: Article

References (30)

1. Global Strategy for the Diagnosis, Management and Prevention of COPD, Global Initiative for Chronic Obstructive Lung Disease (GOLD). 2007; http://www.goldcopd.com.
2. Anthonisen NR, Wright EC, Hodgkin JE. Prognosis in chronic obstructive pulmonary disease. Am Rev Respir Dis 1986; 133(1):14-20.
3. Celli BR, Cote CG, Marin JM, Casanova C, Montes de Oca M, Mendez RA, Pinto Plata V, Cabral HJ. The body-mass index (BMI), airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease. N Engl J Med 2004; 350(10):1005-1012.
4. Nishimura K, Izumi T, Tsukino M, Oga T. Dyspnea is a better predictor of 5-year survival than airway obstruction in patients with COPD. Chest 2002; 121(5):1434-1440.
5. Oga T, Nishimura K, Tsukino M, Sato S, Hajiro T. Analysis of the factors related to mortality in chronic obstructive pulmonary disease/role of exercise capacity and health status. Am J Respir Crit Care Med 2003; 167(4):544-549.
6. Hiraga T, Maekura R, Okuda Y, Okamoto T, Hirotani A, Kitada S, Yoshimura K, Yokota S, Ito M, Ogura T. Prognostic predictors for survival in patients with COPD using cardiopulmonary exercise testing. Clin Physiol Funct Imag 2003; 23(6):324-331.
7. Nocturnal Oxygen Trial Group. Continuous or nocturnal oxygen therapy in hypoxemic chronic obstructive lung disease. Ann Int Med 1980; 93(3):391-398.
8. Chu CM, Chan VL, Lin AWN, Wong IWY, Leung WS, Lai CK. Readmission rates and life threatening events in COPD survivors treated with non-invasive ventilation for acute hypercapnic respiratory failure. Thorax 2004; 59(12):1020-1025.
9. van Gestel AJR, Steier J. Autonomic dysfunction in patients with chronic obstructive pulmonary disease. J Thorac Dis 2010; 2(4):215-222.
10. Maekura R, Hiraga T, Miki K, Kitada S, Yoshimura K, Miki M, Tateishi Y. Difference in the physiological response to exercise in patients with distinct severity of COPD pathology. Respir Care (in press).
11. ERS Task Force. 1997. Clinical exercise testing with reference to lung diseases: indications, standardization and interpretation strategies. Eur Respir J 1997; 10(11):2662-2689.
12. The official statement of American Thoracic Society. Standardization of spirometry, 1994 update. Am J Respir Crit Care Med 1995; 152(3):1107-1136.
13. Borrill ZL, Houghton CM, Woodcock AA, Vestbo J, Singh D. Measuring bronchodilation in COPD clinical trials. Br J Clin Pharmacol 2005; 59(4):379-384.
14. Schols AMWJ, Slangen J, Volovics L, Wouters EFM. Weight loss is a reversible factor in the prognosis of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1998; 157(6 Pt 1):1791-1797.
15. Domingo-Salvany A, Lamarca R, Ferrer M, Garcia-Aymerich J, Alonso J, Felez M, Khalaf A, Marrades RM, Monso E, Serra-Batlles J, Anto JM. Health-related quality of life and mortality in male patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2002; 166(5):680-685.
16. Nici L. Mechanisms and measures of exercise intolerance in chronic obstructive pulmonary disease. Clin Chest Med 2000; 21(4):693-704.
17. Celli BR, MacNee W; ATS/ERS Task Force. Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. Eur Respir J 2006; 27(1):242.
18. Chailleux E, Fauroux B, Binet G, Dautzenberg B, Polu JM. Predictors of survival in patients receiving domiciliary oxygen therapy or mechanical ventilatory: a 10-year analysis of ANTADIR observatory. Chest 1996; 109(3):741-749.
19. Foucher P, Baudouin N, Merati M, Pitard A, Bonniaud P, Reybet-Degat O, Jeannin L. Relative survival analysis of 252 patients with COPD receiving long-term oxygen therapy. Chest 1998; 113(6):1580-1587.
20. Pinto-Plata VM, Cote C, Cabral H, Taylor J, Celli BR. The 6-min walk distance: change over time and value as a predictor of survival in severe COPD. Eur Respir J 2004; 23(1):28-33.
21. Garcia-Rio F, Rojo B, Casitas R, Lores V, Madero R, Romero D, Galera R, Villasante C. Prognostic value of the objective measurement of daily physical activity in patients with COPD. Chest 2012; 142(2):338-346.
22. O'Donnell DE, Hamilton AL, Webb KA. Sensory-mechanical relationships during high-intensity, constant-workrate exercise in COPD. J Appl Physiol 2006; 101(4):1025-1035.
23. Sin DD, Man SF. Why are patients with chronic obstructive pulmonary disease at increased risk of cardiovascular diseases? The potential role of systemic inflammation in chronic obstructive pulmonary disease. Circulation 2003; 107(11):1514-1519.
24. Hirotani A, Maekura R, Okuda Y, Yoshimura K, Moriguchi K, Kitada S, Hiraga T, Ito M, Ogura T, Ogihara T. Exercise-induced electrocardiographic changes in patients with chronic respiratory diseases: differential diagnosis by 99mTc-tetrofosmin SPECT. J Nucl Med 2003; 44(3):325-330.
25. Celli B, Decramer M, Kesten S, Liu D, Mehra S, Tashkin DP, UPLIFT Study Investigators. Mortality in the 4-year trial of tiotropium (UPLIFT) in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2009; 180(10):948-955.
26. Cohn JN, Levine TB, Olivari MT, Garberg V, Lura D, Francis. GS, Simon AB, Rector T. Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure. N Engl J Med 1984; 311(13):819-823.
27. Yoshimura K, Maekura R, Hiraga T, Kitada S, Miki K, Miki M, Tateishi Y. Effects of tiotropium on sympathetic activation during exercise in stable chronic obstructive pulmonary disease patients. Int J Chron Obstruct Pulmon Dis 2012; 7:109-117.
28. Miki K, Maekura R, Nagaya N, Nakazato M, Kimura H, Murakami S, Ohnishi S, Hiraga T, Miki M, Kitada S, Yoshimura K, Tateishi Y, Arimura Y, Matsumoto N, Yoshikawa M, Yamahara K, Kangawa K. Ghrelin treatment of cachectic patients with chronic obstructive pulmonary disease: a multicenter, randomized, double-blind, placebo-controlled trial. PLoS One 2012; 7(5):e35708.
29. Miki K, Maekura R, Hiraga T, Kitada S, Miki M, Yoshimura K, Tateishi Y. Effects of oxygen on exertional dyspnoea and exercise performance in patients with chronic obstructive pulmonary disease. Respirology 2012; 17(1):149-154.
30. ERS Task Force, Palange P, Ward SA, Carlsen KH, Casaburi R, Gallagher CG, Gosselink R, O'Donnell DE, Puente-Maestu L, Schols AM, Singh S, Whipp BJ. Recommendations on the use of exercise testing in clinical practice. Eur Respir J 2007; 29(1):185-209.